nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP3A4—type 2 diabetes mellitus	0.236	1	CbGaD
Dolasetron—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.038	0.0693	CbGbCtD
Dolasetron—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0348	0.0634	CbGbCtD
Dolasetron—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0323	0.0589	CbGbCtD
Dolasetron—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0275	0.0501	CbGbCtD
Dolasetron—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0275	0.0501	CbGbCtD
Dolasetron—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0254	0.0462	CbGbCtD
Dolasetron—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0251	0.0458	CbGbCtD
Dolasetron—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0248	0.0452	CbGbCtD
Dolasetron—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0245	0.0447	CbGbCtD
Dolasetron—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0232	0.0423	CbGbCtD
Dolasetron—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0224	0.0408	CbGbCtD
Dolasetron—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0221	0.0403	CbGbCtD
Dolasetron—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0208	0.038	CbGbCtD
Dolasetron—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0202	0.0369	CbGbCtD
Dolasetron—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.02	0.0364	CbGbCtD
Dolasetron—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.019	0.0347	CbGbCtD
Dolasetron—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0183	0.0333	CbGbCtD
Dolasetron—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0177	0.0322	CbGbCtD
Dolasetron—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.016	0.0291	CbGbCtD
Dolasetron—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0141	0.0256	CbGbCtD
Dolasetron—CYP2C9—Losartan—type 2 diabetes mellitus	0.0129	0.0235	CbGbCtD
Dolasetron—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0121	0.0221	CbGbCtD
Dolasetron—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0116	0.0212	CbGbCtD
Dolasetron—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0116	0.0212	CbGbCtD
Dolasetron—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.011	0.02	CbGbCtD
Dolasetron—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00818	0.0149	CbGbCtD
Dolasetron—CYP3A4—Losartan—type 2 diabetes mellitus	0.00748	0.0136	CbGbCtD
Dolasetron—Atropine—CYP1A2—type 2 diabetes mellitus	0.00016	1	CrCbGaD
Dolasetron—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000139	0.000765	CcSEcCtD
Dolasetron—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000138	0.000763	CcSEcCtD
Dolasetron—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000138	0.000763	CcSEcCtD
Dolasetron—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000138	0.00076	CcSEcCtD
Dolasetron—Anorexia—Valsartan—type 2 diabetes mellitus	0.000138	0.000759	CcSEcCtD
Dolasetron—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000757	CcSEcCtD
Dolasetron—Chest pain—Metformin—type 2 diabetes mellitus	0.000137	0.000756	CcSEcCtD
Dolasetron—Myalgia—Metformin—type 2 diabetes mellitus	0.000137	0.000756	CcSEcCtD
Dolasetron—Malaise—Irbesartan—type 2 diabetes mellitus	0.000137	0.000756	CcSEcCtD
Dolasetron—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000137	0.000753	CcSEcCtD
Dolasetron—Headache—Pioglitazone—type 2 diabetes mellitus	0.000136	0.000752	CcSEcCtD
Dolasetron—Syncope—Irbesartan—type 2 diabetes mellitus	0.000136	0.000752	CcSEcCtD
Dolasetron—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000136	0.000749	CcSEcCtD
Dolasetron—Discomfort—Metformin—type 2 diabetes mellitus	0.000135	0.000747	CcSEcCtD
Dolasetron—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000135	0.000747	CcSEcCtD
Dolasetron—Hypotension—Valsartan—type 2 diabetes mellitus	0.000135	0.000744	CcSEcCtD
Dolasetron—Pain—Gliclazide—type 2 diabetes mellitus	0.000134	0.000741	CcSEcCtD
Dolasetron—Constipation—Gliclazide—type 2 diabetes mellitus	0.000134	0.000741	CcSEcCtD
Dolasetron—Tremor—Losartan—type 2 diabetes mellitus	0.000134	0.000739	CcSEcCtD
Dolasetron—Rash—Glimepiride—type 2 diabetes mellitus	0.000134	0.000738	CcSEcCtD
Dolasetron—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000134	0.000737	CcSEcCtD
Dolasetron—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000134	0.000737	CcSEcCtD
Dolasetron—Rash—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000735	CcSEcCtD
Dolasetron—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000133	0.000735	CcSEcCtD
Dolasetron—Headache—Glimepiride—type 2 diabetes mellitus	0.000133	0.000733	CcSEcCtD
Dolasetron—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000133	0.000732	CcSEcCtD
Dolasetron—Cough—Irbesartan—type 2 diabetes mellitus	0.000133	0.000731	CcSEcCtD
Dolasetron—Headache—Sitagliptin—type 2 diabetes mellitus	0.000132	0.000731	CcSEcCtD
Dolasetron—Anaemia—Losartan—type 2 diabetes mellitus	0.000132	0.000729	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000131	0.000725	CcSEcCtD
Dolasetron—Agitation—Losartan—type 2 diabetes mellitus	0.000131	0.000725	CcSEcCtD
Dolasetron—Oedema—Metformin—type 2 diabetes mellitus	0.000131	0.000725	CcSEcCtD
Dolasetron—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000131	0.000724	CcSEcCtD
Dolasetron—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000131	0.000724	CcSEcCtD
Dolasetron—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000722	CcSEcCtD
Dolasetron—Flushing—Ramipril—type 2 diabetes mellitus	0.000131	0.000721	CcSEcCtD
Dolasetron—Angioedema—Losartan—type 2 diabetes mellitus	0.000131	0.000721	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00013	0.000717	CcSEcCtD
Dolasetron—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00013	0.000715	CcSEcCtD
Dolasetron—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000129	0.000714	CcSEcCtD
Dolasetron—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000714	CcSEcCtD
Dolasetron—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000129	0.000714	CcSEcCtD
Dolasetron—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000129	0.000714	CcSEcCtD
Dolasetron—Shock—Metformin—type 2 diabetes mellitus	0.000129	0.000713	CcSEcCtD
Dolasetron—Malaise—Losartan—type 2 diabetes mellitus	0.000129	0.000711	CcSEcCtD
Dolasetron—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000129	0.000711	CcSEcCtD
Dolasetron—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000129	0.000711	CcSEcCtD
Dolasetron—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000129	0.00071	CcSEcCtD
Dolasetron—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000129	0.00071	CcSEcCtD
Dolasetron—Vertigo—Losartan—type 2 diabetes mellitus	0.000128	0.000709	CcSEcCtD
Dolasetron—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000128	0.000708	CcSEcCtD
Dolasetron—Somnolence—Valsartan—type 2 diabetes mellitus	0.000128	0.000708	CcSEcCtD
Dolasetron—Syncope—Losartan—type 2 diabetes mellitus	0.000128	0.000707	CcSEcCtD
Dolasetron—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000128	0.000706	CcSEcCtD
Dolasetron—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000128	0.000705	CcSEcCtD
Dolasetron—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000127	0.000701	CcSEcCtD
Dolasetron—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000127	0.000701	CcSEcCtD
Dolasetron—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000127	0.000698	CcSEcCtD
Dolasetron—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000127	0.000698	CcSEcCtD
Dolasetron—Palpitations—Losartan—type 2 diabetes mellitus	0.000126	0.000697	CcSEcCtD
Dolasetron—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000126	0.000694	CcSEcCtD
Dolasetron—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000126	0.000693	CcSEcCtD
Dolasetron—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000125	0.000692	CcSEcCtD
Dolasetron—Asthenia—Glyburide—type 2 diabetes mellitus	0.000125	0.000692	CcSEcCtD
Dolasetron—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000125	0.000692	CcSEcCtD
Dolasetron—Anorexia—Metformin—type 2 diabetes mellitus	0.000125	0.000691	CcSEcCtD
Dolasetron—Cough—Losartan—type 2 diabetes mellitus	0.000125	0.000688	CcSEcCtD
Dolasetron—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000125	0.000688	CcSEcCtD
Dolasetron—Fatigue—Valsartan—type 2 diabetes mellitus	0.000124	0.000686	CcSEcCtD
Dolasetron—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000124	0.000685	CcSEcCtD
Dolasetron—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000124	0.000685	CcSEcCtD
Dolasetron—Oedema—Irbesartan—type 2 diabetes mellitus	0.000124	0.000684	CcSEcCtD
Dolasetron—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000124	0.000684	CcSEcCtD
Dolasetron—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000124	0.000684	CcSEcCtD
Dolasetron—Pruritus—Glyburide—type 2 diabetes mellitus	0.000124	0.000683	CcSEcCtD
Dolasetron—Constipation—Valsartan—type 2 diabetes mellitus	0.000123	0.000681	CcSEcCtD
Dolasetron—Fatigue—Orlistat—type 2 diabetes mellitus	0.000123	0.000678	CcSEcCtD
Dolasetron—Hypotension—Metformin—type 2 diabetes mellitus	0.000123	0.000677	CcSEcCtD
Dolasetron—Shock—Irbesartan—type 2 diabetes mellitus	0.000122	0.000673	CcSEcCtD
Dolasetron—Pain—Orlistat—type 2 diabetes mellitus	0.000122	0.000673	CcSEcCtD
Dolasetron—Chest pain—Losartan—type 2 diabetes mellitus	0.000122	0.000672	CcSEcCtD
Dolasetron—Arthralgia—Losartan—type 2 diabetes mellitus	0.000122	0.000672	CcSEcCtD
Dolasetron—Myalgia—Losartan—type 2 diabetes mellitus	0.000122	0.000672	CcSEcCtD
Dolasetron—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000121	0.00067	CcSEcCtD
Dolasetron—Anxiety—Losartan—type 2 diabetes mellitus	0.000121	0.000669	CcSEcCtD
Dolasetron—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000668	CcSEcCtD
Dolasetron—Rash—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000665	CcSEcCtD
Dolasetron—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000121	0.000665	CcSEcCtD
Dolasetron—Discomfort—Losartan—type 2 diabetes mellitus	0.00012	0.000663	CcSEcCtD
Dolasetron—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00012	0.000662	CcSEcCtD
Dolasetron—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00012	0.000661	CcSEcCtD
Dolasetron—Headache—Bromocriptine—type 2 diabetes mellitus	0.00012	0.000661	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00012	0.00066	CcSEcCtD
Dolasetron—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00012	0.00066	CcSEcCtD
Dolasetron—Dry mouth—Losartan—type 2 diabetes mellitus	0.000119	0.000657	CcSEcCtD
Dolasetron—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000652	CcSEcCtD
Dolasetron—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000118	0.000651	CcSEcCtD
Dolasetron—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000118	0.000651	CcSEcCtD
Dolasetron—Confusional state—Losartan—type 2 diabetes mellitus	0.000118	0.000649	CcSEcCtD
Dolasetron—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000117	0.000648	CcSEcCtD
Dolasetron—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000117	0.000646	CcSEcCtD
Dolasetron—Somnolence—Metformin—type 2 diabetes mellitus	0.000117	0.000644	CcSEcCtD
Dolasetron—Oedema—Losartan—type 2 diabetes mellitus	0.000117	0.000644	CcSEcCtD
Dolasetron—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000117	0.000644	CcSEcCtD
Dolasetron—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000117	0.000643	CcSEcCtD
Dolasetron—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000116	0.000639	CcSEcCtD
Dolasetron—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000116	0.000638	CcSEcCtD
Dolasetron—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000116	0.000638	CcSEcCtD
Dolasetron—Tremor—Ramipril—type 2 diabetes mellitus	0.000115	0.000634	CcSEcCtD
Dolasetron—Shock—Losartan—type 2 diabetes mellitus	0.000115	0.000633	CcSEcCtD
Dolasetron—Urticaria—Valsartan—type 2 diabetes mellitus	0.000115	0.000632	CcSEcCtD
Dolasetron—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000114	0.00063	CcSEcCtD
Dolasetron—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000114	0.00063	CcSEcCtD
Dolasetron—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000114	0.000629	CcSEcCtD
Dolasetron—Tachycardia—Losartan—type 2 diabetes mellitus	0.000114	0.000628	CcSEcCtD
Dolasetron—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000114	0.000628	CcSEcCtD
Dolasetron—Fatigue—Metformin—type 2 diabetes mellitus	0.000113	0.000625	CcSEcCtD
Dolasetron—Urticaria—Orlistat—type 2 diabetes mellitus	0.000113	0.000625	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000113	0.000623	CcSEcCtD
Dolasetron—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000113	0.000622	CcSEcCtD
Dolasetron—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000113	0.000622	CcSEcCtD
Dolasetron—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000113	0.000622	CcSEcCtD
Dolasetron—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000113	0.000622	CcSEcCtD
Dolasetron—Agitation—Ramipril—type 2 diabetes mellitus	0.000113	0.000622	CcSEcCtD
Dolasetron—Constipation—Metformin—type 2 diabetes mellitus	0.000112	0.00062	CcSEcCtD
Dolasetron—Angioedema—Ramipril—type 2 diabetes mellitus	0.000112	0.000618	CcSEcCtD
Dolasetron—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000111	0.000614	CcSEcCtD
Dolasetron—Anorexia—Losartan—type 2 diabetes mellitus	0.000111	0.000614	CcSEcCtD
Dolasetron—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000111	0.000613	CcSEcCtD
Dolasetron—Malaise—Ramipril—type 2 diabetes mellitus	0.000111	0.00061	CcSEcCtD
Dolasetron—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.00061	CcSEcCtD
Dolasetron—Rash—Glyburide—type 2 diabetes mellitus	0.00011	0.000608	CcSEcCtD
Dolasetron—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00011	0.000608	CcSEcCtD
Dolasetron—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00011	0.000608	CcSEcCtD
Dolasetron—Vertigo—Ramipril—type 2 diabetes mellitus	0.00011	0.000608	CcSEcCtD
Dolasetron—Syncope—Ramipril—type 2 diabetes mellitus	0.00011	0.000607	CcSEcCtD
Dolasetron—Headache—Glyburide—type 2 diabetes mellitus	0.00011	0.000604	CcSEcCtD
Dolasetron—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000109	0.000602	CcSEcCtD
Dolasetron—Hypotension—Losartan—type 2 diabetes mellitus	0.000109	0.000602	CcSEcCtD
Dolasetron—Palpitations—Ramipril—type 2 diabetes mellitus	0.000108	0.000598	CcSEcCtD
Dolasetron—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000108	0.000597	CcSEcCtD
Dolasetron—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000108	0.000595	CcSEcCtD
Dolasetron—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000108	0.000594	CcSEcCtD
Dolasetron—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000593	CcSEcCtD
Dolasetron—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000107	0.000593	CcSEcCtD
Dolasetron—Cough—Ramipril—type 2 diabetes mellitus	0.000107	0.00059	CcSEcCtD
Dolasetron—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000107	0.00059	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000106	0.000587	CcSEcCtD
Dolasetron—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000106	0.000586	CcSEcCtD
Dolasetron—Convulsion—Ramipril—type 2 diabetes mellitus	0.000106	0.000586	CcSEcCtD
Dolasetron—Pain—Irbesartan—type 2 diabetes mellitus	0.000106	0.000585	CcSEcCtD
Dolasetron—Constipation—Irbesartan—type 2 diabetes mellitus	0.000106	0.000585	CcSEcCtD
Dolasetron—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000105	0.000579	CcSEcCtD
Dolasetron—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000105	0.000578	CcSEcCtD
Dolasetron—Urticaria—Metformin—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Dolasetron—Myalgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Dolasetron—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Dolasetron—Chest pain—Ramipril—type 2 diabetes mellitus	0.000104	0.000576	CcSEcCtD
Dolasetron—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000104	0.000574	CcSEcCtD
Dolasetron—Anxiety—Ramipril—type 2 diabetes mellitus	0.000104	0.000574	CcSEcCtD
Dolasetron—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000104	0.000573	CcSEcCtD
Dolasetron—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000104	0.000573	CcSEcCtD
Dolasetron—Somnolence—Losartan—type 2 diabetes mellitus	0.000104	0.000572	CcSEcCtD
Dolasetron—Asthenia—Valsartan—type 2 diabetes mellitus	0.000104	0.000571	CcSEcCtD
Dolasetron—Discomfort—Ramipril—type 2 diabetes mellitus	0.000103	0.000569	CcSEcCtD
Dolasetron—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000103	0.000567	CcSEcCtD
Dolasetron—Asthenia—Orlistat—type 2 diabetes mellitus	0.000102	0.000564	CcSEcCtD
Dolasetron—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000102	0.000564	CcSEcCtD
Dolasetron—Pruritus—Valsartan—type 2 diabetes mellitus	0.000102	0.000563	CcSEcCtD
Dolasetron—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000102	0.000563	CcSEcCtD
Dolasetron—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000101	0.00056	CcSEcCtD
Dolasetron—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000101	0.000559	CcSEcCtD
Dolasetron—Confusional state—Ramipril—type 2 diabetes mellitus	0.000101	0.000557	CcSEcCtD
Dolasetron—Pruritus—Orlistat—type 2 diabetes mellitus	0.000101	0.000556	CcSEcCtD
Dolasetron—Fatigue—Losartan—type 2 diabetes mellitus	0.000101	0.000555	CcSEcCtD
Dolasetron—Oedema—Ramipril—type 2 diabetes mellitus	0.0001	0.000552	CcSEcCtD
Dolasetron—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.0001	0.000552	CcSEcCtD
Dolasetron—Pain—Losartan—type 2 diabetes mellitus	9.98e-05	0.00055	CcSEcCtD
Dolasetron—Constipation—Losartan—type 2 diabetes mellitus	9.98e-05	0.00055	CcSEcCtD
Dolasetron—Rash—Gliclazide—type 2 diabetes mellitus	9.9e-05	0.000546	CcSEcCtD
Dolasetron—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.89e-05	0.000546	CcSEcCtD
Dolasetron—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.87e-05	0.000545	CcSEcCtD
Dolasetron—Urticaria—Irbesartan—type 2 diabetes mellitus	9.85e-05	0.000543	CcSEcCtD
Dolasetron—Shock—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000543	CcSEcCtD
Dolasetron—Headache—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000543	CcSEcCtD
Dolasetron—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000541	CcSEcCtD
Dolasetron—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000541	CcSEcCtD
Dolasetron—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.8e-05	0.00054	CcSEcCtD
Dolasetron—Tachycardia—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000539	CcSEcCtD
Dolasetron—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000538	CcSEcCtD
Dolasetron—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000534	CcSEcCtD
Dolasetron—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.62e-05	0.00053	CcSEcCtD
Dolasetron—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.54e-05	0.000526	CcSEcCtD
Dolasetron—Dizziness—Valsartan—type 2 diabetes mellitus	9.54e-05	0.000526	CcSEcCtD
Dolasetron—Anorexia—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000526	CcSEcCtD
Dolasetron—Dizziness—Orlistat—type 2 diabetes mellitus	9.43e-05	0.00052	CcSEcCtD
Dolasetron—Asthenia—Metformin—type 2 diabetes mellitus	9.43e-05	0.00052	CcSEcCtD
Dolasetron—Hypotension—Ramipril—type 2 diabetes mellitus	9.35e-05	0.000516	CcSEcCtD
Dolasetron—Pruritus—Metformin—type 2 diabetes mellitus	9.3e-05	0.000513	CcSEcCtD
Dolasetron—Urticaria—Losartan—type 2 diabetes mellitus	9.27e-05	0.000511	CcSEcCtD
Dolasetron—Body temperature increased—Losartan—type 2 diabetes mellitus	9.22e-05	0.000509	CcSEcCtD
Dolasetron—Abdominal pain—Losartan—type 2 diabetes mellitus	9.22e-05	0.000509	CcSEcCtD
Dolasetron—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000504	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000503	CcSEcCtD
Dolasetron—Rash—Valsartan—type 2 diabetes mellitus	9.1e-05	0.000502	CcSEcCtD
Dolasetron—Dermatitis—Valsartan—type 2 diabetes mellitus	9.09e-05	0.000501	CcSEcCtD
Dolasetron—Headache—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000499	CcSEcCtD
Dolasetron—Diarrhoea—Metformin—type 2 diabetes mellitus	8.99e-05	0.000496	CcSEcCtD
Dolasetron—Rash—Orlistat—type 2 diabetes mellitus	8.99e-05	0.000496	CcSEcCtD
Dolasetron—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.98e-05	0.000496	CcSEcCtD
Dolasetron—Dermatitis—Orlistat—type 2 diabetes mellitus	8.98e-05	0.000495	CcSEcCtD
Dolasetron—Headache—Orlistat—type 2 diabetes mellitus	8.93e-05	0.000493	CcSEcCtD
Dolasetron—Dyspnoea—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000492	CcSEcCtD
Dolasetron—Asthenia—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.000491	CcSEcCtD
Dolasetron—Somnolence—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000491	CcSEcCtD
Dolasetron—Dyspepsia—Ramipril—type 2 diabetes mellitus	8.81e-05	0.000486	CcSEcCtD
Dolasetron—Pruritus—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000484	CcSEcCtD
Dolasetron—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.7e-05	0.00048	CcSEcCtD
Dolasetron—Dizziness—Metformin—type 2 diabetes mellitus	8.69e-05	0.000479	CcSEcCtD
Dolasetron—Fatigue—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000476	CcSEcCtD
Dolasetron—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.6e-05	0.000474	CcSEcCtD
Dolasetron—Constipation—Ramipril—type 2 diabetes mellitus	8.56e-05	0.000472	CcSEcCtD
Dolasetron—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000468	CcSEcCtD
Dolasetron—Asthenia—Losartan—type 2 diabetes mellitus	8.37e-05	0.000462	CcSEcCtD
Dolasetron—Rash—Metformin—type 2 diabetes mellitus	8.28e-05	0.000457	CcSEcCtD
Dolasetron—Dermatitis—Metformin—type 2 diabetes mellitus	8.28e-05	0.000457	CcSEcCtD
Dolasetron—Pruritus—Losartan—type 2 diabetes mellitus	8.26e-05	0.000455	CcSEcCtD
Dolasetron—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000455	CcSEcCtD
Dolasetron—Headache—Metformin—type 2 diabetes mellitus	8.23e-05	0.000454	CcSEcCtD
Dolasetron—Dizziness—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000452	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000451	CcSEcCtD
Dolasetron—Diarrhoea—Losartan—type 2 diabetes mellitus	7.98e-05	0.00044	CcSEcCtD
Dolasetron—Urticaria—Ramipril—type 2 diabetes mellitus	7.95e-05	0.000439	CcSEcCtD
Dolasetron—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000436	CcSEcCtD
Dolasetron—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.91e-05	0.000436	CcSEcCtD
Dolasetron—Rash—Irbesartan—type 2 diabetes mellitus	7.82e-05	0.000431	CcSEcCtD
Dolasetron—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000431	CcSEcCtD
Dolasetron—Headache—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000429	CcSEcCtD
Dolasetron—Dizziness—Losartan—type 2 diabetes mellitus	7.72e-05	0.000426	CcSEcCtD
Dolasetron—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000407	CcSEcCtD
Dolasetron—Rash—Losartan—type 2 diabetes mellitus	7.36e-05	0.000406	CcSEcCtD
Dolasetron—Dermatitis—Losartan—type 2 diabetes mellitus	7.35e-05	0.000406	CcSEcCtD
Dolasetron—Headache—Losartan—type 2 diabetes mellitus	7.31e-05	0.000403	CcSEcCtD
Dolasetron—Asthenia—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000396	CcSEcCtD
Dolasetron—Pruritus—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000391	CcSEcCtD
Dolasetron—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.85e-05	0.000378	CcSEcCtD
Dolasetron—Dizziness—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000365	CcSEcCtD
Dolasetron—Rash—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000348	CcSEcCtD
Dolasetron—Dermatitis—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000348	CcSEcCtD
Dolasetron—Headache—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000346	CcSEcCtD
Dolasetron—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	1.75e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	1.75e-05	0.000509	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	1.73e-05	0.000504	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	1.73e-05	0.000504	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.72e-05	0.000502	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.69e-05	0.000493	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	1.69e-05	0.000491	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	1.69e-05	0.000491	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	1.69e-05	0.000491	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	1.69e-05	0.000491	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.69e-05	0.000491	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.68e-05	0.000489	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.67e-05	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.67e-05	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.67e-05	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.67e-05	0.000487	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.67e-05	0.000487	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	1.63e-05	0.000476	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.62e-05	0.000472	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.57e-05	0.000456	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.56e-05	0.000454	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	1.54e-05	0.000449	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	1.54e-05	0.000449	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.53e-05	0.000446	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.53e-05	0.000446	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	1.5e-05	0.000438	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.49e-05	0.000434	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	1.43e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	1.43e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	1.43e-05	0.000418	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.42e-05	0.000414	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.42e-05	0.000414	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.42e-05	0.000414	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	1.38e-05	0.000401	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	1.38e-05	0.000401	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.37e-05	0.000399	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.37e-05	0.000399	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.36e-05	0.000397	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.36e-05	0.000397	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	1.32e-05	0.000386	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.32e-05	0.000386	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.31e-05	0.000382	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.31e-05	0.000382	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.3e-05	0.000379	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.3e-05	0.000378	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.3e-05	0.000378	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.29e-05	0.000376	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.29e-05	0.000375	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.28e-05	0.000372	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.28e-05	0.000372	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.28e-05	0.000372	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.27e-05	0.000369	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.27e-05	0.000369	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.27e-05	0.000369	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.24e-05	0.00036	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.23e-05	0.000358	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.2e-05	0.00035	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.19e-05	0.000347	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.17e-05	0.000342	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.14e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.14e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.14e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.13e-05	0.000328	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.12e-05	0.000325	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.12e-05	0.000325	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.1e-05	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.1e-05	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.1e-05	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.1e-05	0.000321	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.1e-05	0.000321	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.09e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.09e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.09e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.09e-05	0.000317	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.07e-05	0.000311	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	0.000304	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.04e-05	0.000302	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.03e-05	0.000301	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.01e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.01e-05	0.000294	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1e-05	0.000292	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.84e-06	0.000286	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.83e-06	0.000286	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.72e-06	0.000283	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	9.69e-06	0.000282	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	9.61e-06	0.00028	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.38e-06	0.000273	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.38e-06	0.000273	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.38e-06	0.000273	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	9.05e-06	0.000263	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.99e-06	0.000262	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.99e-06	0.000262	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	8.97e-06	0.000261	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	8.87e-06	0.000258	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	8.87e-06	0.000258	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	8.79e-06	0.000256	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	8.79e-06	0.000256	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	8.69e-06	0.000253	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.66e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.66e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	8.64e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	8.64e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	8.64e-06	0.000252	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	8.62e-06	0.000251	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	8.59e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.57e-06	0.00025	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	8.56e-06	0.000249	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	8.56e-06	0.000249	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	8.56e-06	0.000249	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	8.51e-06	0.000248	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.51e-06	0.000248	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.43e-06	0.000246	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.36e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.36e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.36e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	8.36e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.34e-06	0.000243	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	8.26e-06	0.000241	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.86e-06	0.000229	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	7.75e-06	0.000226	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	7.75e-06	0.000226	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	7.75e-06	0.000226	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.7e-06	0.000224	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.68e-06	0.000224	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.68e-06	0.000224	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.68e-06	0.000224	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	7.61e-06	0.000221	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	7.54e-06	0.00022	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	7.54e-06	0.000219	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	7.47e-06	0.000218	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.38e-06	0.000215	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	7.37e-06	0.000215	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.36e-06	0.000214	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	7.31e-06	0.000213	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.11e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.11e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.11e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.11e-06	0.000207	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.09e-06	0.000206	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	7.03e-06	0.000205	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.01e-06	0.000204	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.01e-06	0.000204	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.95e-06	0.000202	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.95e-06	0.000202	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.83e-06	0.000199	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.82e-06	0.000198	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.77e-06	0.000197	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.74e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.72e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.72e-06	0.000196	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.66e-06	0.000194	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.66e-06	0.000194	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.34e-06	0.000185	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.92e-06	0.000172	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.8e-06	0.000169	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.8e-06	0.000169	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.79e-06	0.000169	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.79e-06	0.000169	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.76e-06	0.000168	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.74e-06	0.000167	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.74e-06	0.000167	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.71e-06	0.000166	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.69e-06	0.000166	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.68e-06	0.000166	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.65e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.65e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.65e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.64e-06	0.000164	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.61e-06	0.000163	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.52e-06	0.000161	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.51e-06	0.000161	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.47e-06	0.000159	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.45e-06	0.000159	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.37e-06	0.000156	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.32e-06	0.000155	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.27e-06	0.000154	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	5.23e-06	0.000152	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.16e-06	0.00015	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.14e-06	0.00015	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	5.12e-06	0.000149	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	5.1e-06	0.000148	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.07e-06	0.000148	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.07e-06	0.000148	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.07e-06	0.000148	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.01e-06	0.000146	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.97e-06	0.000145	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.97e-06	0.000145	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.95e-06	0.000144	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.93e-06	0.000144	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.9e-06	0.000143	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.82e-06	0.00014	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.75e-06	0.000138	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.71e-06	0.000137	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.66e-06	0.000136	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.63e-06	0.000135	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.62e-06	0.000134	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.58e-06	0.000133	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.58e-06	0.000133	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.51e-06	0.000131	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.47e-06	0.00013	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.43e-06	0.000129	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.42e-06	0.000129	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.4e-06	0.000128	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.39e-06	0.000128	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.39e-06	0.000128	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.38e-06	0.000128	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.37e-06	0.000127	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.33e-06	0.000126	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.85e-06	0.000112	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.82e-06	0.000111	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.79e-06	0.00011	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.79e-06	0.00011	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.78e-06	0.00011	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.77e-06	0.00011	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.74e-06	0.000109	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.72e-06	0.000108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.61e-06	0.000105	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.51e-06	0.000102	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.46e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.45e-06	0.0001	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.43e-06	9.99e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.37e-06	9.83e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.36e-06	9.79e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.31e-06	9.64e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.31e-06	9.64e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.28e-06	9.56e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.28e-06	9.56e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.28e-06	9.54e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.23e-06	9.42e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.1e-06	9.04e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.04e-06	8.87e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.03e-06	8.82e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	3e-06	8.74e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.95e-06	8.59e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.9e-06	8.44e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.89e-06	8.41e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.86e-06	8.32e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.52e-06	7.33e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.47e-06	7.19e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.26e-06	6.59e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.16e-06	6.3e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.16e-06	6.3e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.98e-06	5.76e-05	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	4.43e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-06	4.39e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.95e-07	2.9e-05	CbGpPWpGaD
